Cargando…
Tocilizumab: Candidaemia and Off-label-use: 3 case reports
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7442180/ http://dx.doi.org/10.1007/s40278-020-82530-2 |
Ejemplares similares
-
Dexamethasone/methylprednisolone/tocilizumab: Candidaemia: case report
Publicado: (2021) -
Tocilizumab: Off-label use and neutropenia: case report
Publicado: (2021) -
Tocilizumab: Acute hypertriglyceridaemia and off-label use: case report
Publicado: (2020) -
Tocilizumab: Off label use and lack of efficacy: case report
Publicado: (2021) -
Tocilizumab: Anaphylaxis following off-label use: case report
Publicado: (2021)